Biopsies from all patients
|
Revised histological score aGvHD
|
Revised clinical aGvHD
|
0.6364
| | |
Revised histological score cGvHD
|
Revised clinical cGvHD overall
|
0.7843
| | |
Revised histological score cGvHD
|
Revised max. clinical cGvHD score skin
|
0.2382
| | |
Limited 0–50% skin involvement
| | | |
Extensive > 50% skin involvement
| | | |
Biopsies from aGvHD patients
|
Revised histological aGvHD
|
Revised clinical aGvHD
|
0.3409
| | |
Revised histological aGvHD
|
Max. documented clinical aGvHD
|
0.3498
| | |
Revised histological aGvHD
|
Survival
|
0.0744
| | |
Revised clinical GvHD
|
Survival
|
0.9739
| | |
Biopsies from cGvHD patients
|
Revised histological cGvHD
|
Revised clinical cGvHD overall
|
0.5105
| | |
Revised histological cGvHD
|
Revised clinical cGvHD skin
|
0.157
| | |
Limited 0–50% skin involvement
| | | |
Extensive > 50% skin involvement
| | | |
Revised histological cGvHD
|
Revised max. clinical cGvHD score skin
|
0.157
| | |
Limited 0–50% skin involvement
| | | |
Extensive > 50% skin involvement
| | | |
Revised histological cGvHD
|
Survival
|
0.4465
| | |
Revised clinical cGvHD overall
|
Survival
|
0.0002
| | |
Revised max. clinical cGvHD score skin
|
Survival
|
0.1249
| | |
Limited 0–50% skin involvement
| | | | |
Extensive > 50% skin involvement
| | | | |